Clinical Study

Neurostar Transcranial Magnetic Stimulation (Tms) Therapy Study In Depressed Adolescents

Posted Date: Oct 6, 2017

  • Investigator: Jeffrey Strawn
  • Specialties: Depression, Adolescent Psychiatry/Psychology, Psychiatry/Psychology
  • Type of Study: Device

The purpose of this study is to get information about using TMS as a treatment for depression in adolescents with Major Depressive Disorder (MDD) who have not had a good response to medication to treat their depression. The NeuroStar has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of Major Depressive Disorder (MDD) in adults.

Criteria:

- Patients 12-21 Years Old - Resistance To Prior Antidepressant Medication - Depression Illness Lasting Greater Than 4 Weeks And Less Than 3 Years

Keywords:

Adolescents, Depression, Psychiatry, Transcranial Magnetic Stimulation (Tms) Therapy

For More Information:

Sara Varney
(513) 558-2931
varneysa@ucmail.uc.edu


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.